G
Gala Therapeutics
Innovative bronchoscopic therapy reducing mucus cells in chronic bronchitis patients with non-thermal pulsed electric fields
About Gala Therapeutics
Gala Therapeutics, Inc. is a medical device company focused on developing innovative treatments for pulmonary diseases, specifically chronic bronchitis. The company operates in the healthcare sector, targeting patients suffering from chronic bronchitis, a condition characterized by excess mucus production and persistent cough. Gala Therapeutics' flagship product, RheOx, is a bronchoscopic therapy that utilizes non-thermal pulsed electric fields to reduce mucus-producing cells in the airways, thereby improving patients' quality of life. The procedure is minimally invasive and can be performed by a single operator, making it a convenient option for both patients and healthcare providers. The company generates revenue through the sale of its RheOx system and related services. Gala Therapeutics is currently conducting clinical studies to further validate the efficacy and safety of its technology. The market for chronic bronchitis treatment is substantial, with approximately 15 million people affected in Europe and 9 million in the United States. Gala Therapeutics aims to capture a significant share of this market by offering a unique and effective solution for a condition that has limited treatment options.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- Menlo Park, United States
- Sector
- Health
News
Open roles
Gala Therapeutics in the Menlo Park ecosystem
The Gala Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Gala Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gala Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


